2 LT Bloedon , O Philippe & PO Szapary (2004) Flaxseed and cardiovascular risk. Nutr Rev 62, 18–27.
3 E Ghisalberti (1997) Cardiovascular activity of naturally occurring lignans. Phytomedicine 4, 151–166.
5 C Eliasson , A Kamal-Eldin , R Andersson & P Aman (2003) High-performance liquid chromatographic analysis of secoisolariciresinol diglucoside and hydroxycinnamic acid glucosides in flaxseed by alkaline extraction. J Chromatography A 1012, 151–159.
8 K Prasad (2005) Hypocholesterolemic and antiatherosclerotic effect of flax lignan complex isolated from flaxseed. Atherosclerosis 179, 269–275.
9 K Prasad (1999) Reduction of serum cholesterol and hypercholesterolemic atherosclerosis in rabbits by secoisolariciresinol diglucoside isolated from flaxseed. Circulation 99, 1355–1362.
10 SJ Bhathena , AA Ali , C Haudenschild , P Latham , T Ranich , AI Mohamed , CT Hansen & MT Velasquez (2003) Dietary flaxseed meal is more protective than soy protein concentrate against hypertriglyceridemia and steatosis of the liver in an animal model of obesity. J Am Coll Nutr 22, 157–164.
11 K Yamashita , S Ikeda & M Obayashi (2003) Comparative effects of flaxseed and sesame seed on vitamin E and cholesterol levels in rats. Lipids 38, 1249–1255.
12 K Prasad (1997) Dietary flax seed in prevention of hypercholesterolemic atherosclerosis. Atherosclerosis 132, 69–76.
13 EA Lucas , SA Lightfoot , LJ Hammond , (2004) Flaxseed reduces plasma cholesterol and atherosclerotic lesion formation in ovariectomized Golden Syrian hamsters. Atherosclerosis 173, 223–229.
14 T Sano , E Oda , T Yamashita , H Shiramasa , Y Ijiri & J Yamamoto (2003) Antithrombic and anti-atherogenic effects of partially defatted flaxseed meal using a laser-induced thrombosis test in apolipoprotein E and low-density lipoprotein receptor deficient mice. Blood Coagul Fibrinolysis 14, 707–712.
19 A Brzezinski & A Debi (1999) Phytoestrogens: the “natural” selective estrogen receptor modulators? Eur J Obstet Gynecol Reprod Biol 85, 47–51.
20 W Insull Jr, MH Davidson , PM Kulkarni , S Siddhanti , AV Ciaccia & CA Keech (2005) Effects of raloxifene and low-dose simvastatin coadministration on plasma lipids in postmenopausal women with primary hypercholesterolemia. Metabolism 54, 939–946.
21 C Lemieux , Y Gelinas , J Lalonde , F Labrie , K Cianflone & Y Deshaies (2005) Hypolipidemic action of the SERM acolbifene is associated with decreased liver MTP and increased SR-BI and LDL receptors. J Lipid Res 46, 1285–1294.
22 W Demark-Wahnefried , CN Robertson , PJ Walther , TJ Polascik , DF Paulson & RT Vollmer (2004) Pilot study to explore effects of low-fat, flaxseed-supplemented diet on proliferation of benign prostatic epithelium and prostate-specific antigen. Urology 63, 900–904.
23 W Demark-Wahnefried , DT Price , TJ Polascik , CN Robertson , EE Anderson , DF Paulson , PJ Walther , M Gannon & RT Vollmer (2001) Pilot study of dietary fat restriction and flaxseed supplementation in men with prostate cancer before surgery: exploring the effects on hormonal levels, prostate-specific antigen, and histopathologic features. Urology 58, 47–52.
24 C Stuglin & K Prasad (2005) Effect of flaxseed consumption on blood pressure, serum lipids, hemopoietic system and liver and kidney enzymes in healthy humans. J Cardiovasc Pharmacol Ther 10, 23–27.
25 S Dodin , A Lemay , H Jacques , F Legare , JC Forest & B Masse (2005) Effect of flaxseed consumption on blood pressure, serum lipids, hemopoietic system, and symptoms in menopausal women: a randomized, double-blind, wheat germ placebo-controlled clinical trial. J Clin Endocrinol Metab 90, 1390–1397.
27 ST Chen , SH Ferng , CS Yang , SJ Peng , HR Lee & JR Chen (2005) Variable effects of soy protein on plasma lipids in hyperlipidemic and normolipidemic hemodialysis patients. Am J Kidney Dis 46, 1099–1106.
28 Y Henkin & I Shai (2003) Dietary treatment of hypercholesterolemia: can we predict long-term success? J Am Coll Nutr 22, 555–561.
29 K Prasad , SV Mantha , AD Muir & ND Westcott (1998) Reduction of hypercholesterolemic atherosclerosis by CDC-flaxseed with very low α-linolenic acid. Atherosclerosis 136, 367–375.
30 EA Lucas , RD Wild , LJ Hammond , DA Khalil , S Juma , BP Daggy , BJ Stoecker & BH Arjmandi (2002) Flaxseed improves lipid profile without altering biomarkers of bone metabolism in postmenopausal women. J Clin Endocrinol Metab 87, 1527–1532.
31 MT Clandinin , A Foxwell , YK Goh , K Layne & JA Jumpsen (1997) Omega-3 fatty acid intake results in a relationship between the fatty acid composition of LDL cholesterol ester and LDL cholesterol content in humans. Biochim Biophys Acta 1346, 247–252.
32 PJ Nestel , SE Pomeroy , T Sasahara , T Yamashita , YL Liang , AM Dart , GL Jennings , M Abbey & JD Cameron (1997) Arterial compliance in obese subjects is improved with dietary plant n-3 fatty acid from flaxseed oil despite increased LDL oxidizability. Arterioscler Thromb Vasc Biol 17, 1163–1170.
34 A Lemay , S Dodin , N Kadri , H Jacques & JC Forest (2002) Flaxseed dietary supplement versus hormone replacement therapy in hypercholesterolemic menopausal women. Obstet Gynecol 100, 495–504.
36 M Vanharanta , S Voutilainen , TA Lakka , M van der Lee , H Adlercreutz & JT Salonen (1999) Risk of acute coronary events according to serum concentrations of enterolactone: a prospective population-based case-control study. Lancet 354, 2112–2115.
46 MS Morton , G Wilcox , ML Wahlqvist & K Griffiths (1994) Determination of lignans and isoflavonoids in human female plasma following dietary supplementation. J Endocrinol 142, 251–259.